Publications by authors named "Shahin Jamal"

Claim this Profile
C
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides.
Carrie Ye, Roko P A Nikolic, May Choi, Aurore Viviane Fifi-Mah, Jeffrey Graham, Shahin Jamal

J Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases.
Carrie Ye, Roko P A Nikolic, May Choi, Aurore Viviane Fifi-Mah, Jeffrey Graham, Shahin Jamal

J Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acrocyanosis After Immunotherapy: Vasculitis or Vasculopathy? New Iatrogenic Disease Case Series From CanRIO.
Yuliya Lytvyn, Megan E Himmel, Carrie Ye, Shahin Jamal, Alexandra P Saltman

J Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors and the pediatric rheumatologist: a pediatric needs assessment.
John Storwick, Carrie Ye, Shahin Jamal, Nancy Maltez, Mercedes Chan

Pediatr Rheumatol Online J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO).
Jenny Xiaoyu Li, Marie Hudson, Carrie Ye, Janet Roberts, Aurore Fifi-Mah, Shahin Jamal

J Rheumatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Knowledge Dissemination of Rheumatic Toxicities of Cancer Immunotherapy: A Web-Based Educational Initiative.
Janet Roberts, Shahin Jamal, Marie Hudson, Steven Katz, Daniel Ennis

Musculoskeletal Care· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronicity of Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno-Oncology Database.
Alexandra Ladouceur, Shahin Jamal, Alexandra Saltman, Megan Himmel, Marie Hudson

ACR Open Rheumatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False-positive Findings of Large Vessel Vasculitis on FDG-PET in Patients Treated With Immune Checkpoint Inhibitors.
Dylan Johnson, Shahin Jamal, Ryan W Hung, Carrie Ye

J Immunother· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2.
Roko P A Nikolic, Jordi Pardo Pardo, Janet E Pope, Claire E H Barber, Cheryl Barnabe, Shahin Jamal

J Rheumatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor-Associated Remitting Seronegative Symmetrical Synovitis With Pitting Edema: Description of a New Entity by CanRIO.
Azin Rouhi, Shahin Jamal, Lourdes Gonzales Arreola, David Moon, Marie Hudson

J Rheumatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events.
Alexandra Ladouceur, Aiarpi Ezdoglian, Jeffrey A Sparks, Marie Hudson, Shahin Jamal

Rheum Dis Clin North Am· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo Connective Tissue Disorders as Immune-related Adverse Events.
Lindsay Kristin Cho, Shahin Jamal

Rheum Dis Clin North Am· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1.
Glen S Hazlewood, Pooneh Akhavan, Jordi Pardo Pardo, Arnav Agarwal, Orit Schieir, Shahin Jamal

J Rheumatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group.
Nilasha Ghosh, Nina Couette, Wouter H van Binsbergen, Sophia C Weinmann, Bridget Jivanelli, Shahin Jamal

Semin Arthritis Rheum· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs.
Glen S Hazlewood, Jordi Pardo Pardo, Cheryl Barnabe, Orit Schieir, Claire E H Barber, Shahin Jamal

J Rheumatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study.
Sophie Stukas, George Goshua, Angus Kinkade, Rebecca Grey, Gregory Mah, Shahin Jamal

Lancet Reg Health Am· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgG4-related prostatitis manifesting as urinary obstruction in a 28-year-old male.
Aria Jazdarehee, Azin Ahrari, Drew Bowie, Silvia D Chang, Henry Tran, Shahin Jamal

BMC Urol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology.
Sabrina Hoa, Linda Laaouad, Janet Roberts, Daniel Ennis, Carrie Ye, Shahin Jamal

Cancer Immunol Immunother· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome.
Luke Y C Chen, Catherine M Biggs, Shahin Jamal, Sophie Stukas, Cheryl L Wellington

Cell Rep Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing rheumatology residents' decision on future practice location.
Justin Shamis, Jessica Widdifield, Michelle Batthish, Dharini Mahendira, Shahin Jamal

Can Med Educ J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
Marie Kostine, Axel Finckh, Clifton O Bingham, Karen Visser, Jan Leipe, Shahin Jamal

Ann Rheum Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.
James T England, Alym Abdulla, Catherine M Biggs, Agnes Y Y Lee, Kevin A Hay, Shahin Jamal

Blood Rev· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rheumatic immune-related adverse events associated with cancer immunotherapy: A nationwide multi-center cohort.
Janet Roberts, Daniel Ennis, Marie Hudson, Carrie Ye, Alexandra Saltman, Shahin Jamal

Autoimmun Rev· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote assessment via video evaluation (RAVVE): a pilot study to trial video-enabled peer feedback on clinical performance.
Kendall Ho, Christopher Yao, Helen Novak Lauscher, Barry E Koehler, Kamran Shojania, Shahin Jamal

BMC Med Educ· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years.
Janet E Pope, Edward Keystone, Shahin Jamal, Lisy Wang, Lara Fallon

ACR Open Rheumatol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis